Skip to content

2024 January 11 release
Compare
Choose a tag to compare
@brendanreardon brendanreardon released this 11 Jan 19:37
· 11 commits to main since this release
v.2024-01-11
13609f2
This commit was created on GitHub.com and signed with GitHub’s verified signature. The key has expired.
GPG key ID: 4AEE18F83AFDEB23
Expired
Learn about vigilant mode.

Added entries:

  • (FDA) ERBB2 amplification and sensitivity to neratinib in combination with capecitabine for patients with breast cancer.

Revised entries:

  • (FDA) ERBB2 amplification and sensitivity to neratinib for patients with breast cancer, received an updated description and citation.

The description or context within 14 records also received minor updates to improve clarity.

In addition, we updated our S.O.P. for curating clinical guidelines from the NCCN to reflect their referencing guide. All relevant records within this database were updated in our November 2023 release.

Assets 2
Loading